Autolus Therapeutics (AUTL) Share-based Compensation (QoQ) (2019 - 2025)
Autolus Therapeutics (AUTL) Share-based Compensation (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.22% |
| Sep 30, 2025 | -10.67% |
| Jun 30, 2025 | 49.74% |
| Mar 31, 2025 | -54.00% |
| Dec 31, 2024 | 55.05% |
| Sep 30, 2024 | 36.97% |
| Jun 30, 2024 | 28.50% |
| Mar 31, 2024 | 3,725.40% |
| Dec 31, 2023 | -100.76% |
| Sep 30, 2023 | -70.04% |
| Jun 30, 2023 | 436.05% |
| Mar 31, 2023 | 51.48% |
| Dec 31, 2022 | 2.34% |
| Sep 30, 2022 | 14.20% |
| Jun 30, 2022 | 24.87% |
| Mar 31, 2022 | 112.59% |
| Dec 31, 2021 | -166.58% |
| Sep 30, 2021 | 2,080.23% |
| Jun 30, 2021 | 291.04% |
| Mar 31, 2021 | -106.05% |